Aspartate Aminotransferase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
by Luke Spooner
by Luke Spooner
-
'''Aspartate Aminotransferase''' (AAT), also known as '''Glutamic aspartic transaminase''', '''glutamic oxaloacetic transaminase''', and '''transaminase A''' is an enzyme that is a member of the class-I pyridoxal-phosphate-dependent aminotransferase family <ref name ="AST family and name">PMID:20977429</ref>. It is coded by the gene GOT1<ref name ="AST gene">PMID:4193185</ref>. It is a homodimer that is 413 amino acids long and serves a critical role in amino acid and carbohydrate metabolism, ureogenesis, and the transfer of reducing equivalents into the mitochondria and chloroplast<ref name ="AST ROLES AND STRUCTURE">PMID:10708649</ref>. Within prokaryote cells it is exclusively found in the cytosol, but in eukaryotic cells there are cytosol, mitochondrial, and chloroplast isozymes<ref name ="AST family and name"/><ref name ="AST Structure"/>.
+
'''Aspartate Aminotransferase''' (AAT), also known as '''Glutamic aspartic transaminase''', '''glutamic oxaloacetic transaminase''', '''prephenate aminotransferase''' and '''transaminase A''' is an enzyme that is a member of the class-I pyridoxal-phosphate-dependent aminotransferase family <ref name ="AST family and name">PMID:20977429</ref>. It is coded by the gene GOT1<ref name ="AST gene">PMID:4193185</ref>. It is a homodimer that is 413 amino acids long and serves a critical role in amino acid and carbohydrate metabolism, ureogenesis, and the transfer of reducing equivalents into the mitochondria and chloroplast<ref name ="AST ROLES AND STRUCTURE">PMID:10708649</ref>. Within prokaryote cells it is exclusively found in the cytosol, but in eukaryotic cells there are cytosol, mitochondrial, and chloroplast isozymes<ref name ="AST family and name"/><ref name ="AST Structure"/>.
In the human body it is produced in the brain, skeletal muscles, liver, pancreas, red blood cells, and kidneys <ref name ="AST ORGANS">PMID:2569674</ref><ref name ="Liver damage"/>. The wide range of tissues in which it is made, separates it from the similar enzyme alanine transaminase (ALT) which is found primarily in the liver<ref name ="Liver damage">PMID:10831269</ref>. The level of AAT in the body can be used as a marker for tissue disease or damage<ref name ="Liver damage"/>. As well, AAT and ALT levels can be compared to pinpoint whether tissue damage is primarily found within the liver<ref name ="Liver damage">PMID:12546613</ref>.
In the human body it is produced in the brain, skeletal muscles, liver, pancreas, red blood cells, and kidneys <ref name ="AST ORGANS">PMID:2569674</ref><ref name ="Liver damage"/>. The wide range of tissues in which it is made, separates it from the similar enzyme alanine transaminase (ALT) which is found primarily in the liver<ref name ="Liver damage">PMID:10831269</ref>. The level of AAT in the body can be used as a marker for tissue disease or damage<ref name ="Liver damage"/>. As well, AAT and ALT levels can be compared to pinpoint whether tissue damage is primarily found within the liver<ref name ="Liver damage">PMID:12546613</ref>.
Line 27: Line 27:
=='''Clinical Applications'''==
=='''Clinical Applications'''==
The levels of AAT in the body are indicative of tissue damage and disease<ref name ="TISSUE DAMAGE">PMID:8432855</ref>. Normally AAT is found in minimal amounts within the blood, however when the organs mentioned above are damaged, AAT is released into the blood<ref name ="TISSUE DAMAGE"/>. The amount released is proportional to the level of damage sustained<ref name ="TISSUE DAMAGE"/>. AAT levels have been shown to rise substantially within 6 hours of the initial tissue degradation and can stay elevated for up to 4 days<ref name ="TISSUE DAMAGE"/>. AAT levels when compared with the levels of other enzymes can be used by physicians to determine where in the body the damage has taken place<ref name ="Liver damage"/>. Comparisons with ALT have proven particularly useful in identifying liver damage such as cirrhosis and hepatitis<ref name ="Liver damage"/>. Under normal condition, AAT levels within men are 6-34 IU/L and for women it is 8-40 IU/L<ref name ="TISSUE DAMAGE"/>.
The levels of AAT in the body are indicative of tissue damage and disease<ref name ="TISSUE DAMAGE">PMID:8432855</ref>. Normally AAT is found in minimal amounts within the blood, however when the organs mentioned above are damaged, AAT is released into the blood<ref name ="TISSUE DAMAGE"/>. The amount released is proportional to the level of damage sustained<ref name ="TISSUE DAMAGE"/>. AAT levels have been shown to rise substantially within 6 hours of the initial tissue degradation and can stay elevated for up to 4 days<ref name ="TISSUE DAMAGE"/>. AAT levels when compared with the levels of other enzymes can be used by physicians to determine where in the body the damage has taken place<ref name ="Liver damage"/>. Comparisons with ALT have proven particularly useful in identifying liver damage such as cirrhosis and hepatitis<ref name ="Liver damage"/>. Under normal condition, AAT levels within men are 6-34 IU/L and for women it is 8-40 IU/L<ref name ="TISSUE DAMAGE"/>.
 +
 +
==3D structures of aspartate aminotransferase==
 +
[[Aspartate aminotransferase 3D structures]]
 +
</StructureSection>
</StructureSection>
==3D structures of aspartate aminotransferase==
==3D structures of aspartate aminotransferase==
Line 48: Line 52:
**[[2z9v]] – MlAAT + pyridoxamine<br />
**[[2z9v]] – MlAAT + pyridoxamine<br />
-
*Aspartate aminotransferase binary complex with pyridoxal phosphate
+
*Aspartate aminotransferase binary complex with pyridoxal phosphate (PLP)
-
**[[1asm]], [[1asn]], [[1ars]], [[1art]] - EcAAT + pyridoxal phosphate<br />
+
**[[1asm]], [[1asn]], [[1ars]], [[1art]] - EcAAT + PLP<br />
-
**[[3aat]], [[1aam]], [[1aaw]], [[1asf]], [[1asg]], [[1ahe]], [[1ahg]], [[5eaa]], [[1g4v]], [[1g4x]], [[1g7w]], [[1g7x]], [[1ix6]], [[1ix8]], [[2d65]], [[2d66]], [[2d7y]], [[3zzj]], [[3zzk]], [[4a00]] - EcAAT (mutant) + pyridoxal phosphate<br />
+
**[[3aat]], [[1aam]], [[1aaw]], [[1asf]], [[1asg]], [[1ahe]], [[1ahg]], [[5eaa]], [[1g4v]], [[1g4x]], [[1g7w]], [[1g7x]], [[1ix6]], [[1ix8]], [[2d65]], [[2d66]], [[2d7y]], [[3zzj]], [[3zzk]], [[4a00]] - EcAAT (mutant) + PLP<br />
-
**[[7aat]], [[8aat]], [[1tar]], [[1tat]], [[2cst]] - cAAT + pyridoxal phosphate<br />
+
**[[7aat]], [[8aat]], [[1tar]], [[1tat]], [[2cst]] - cAAT + PLP<br />
-
**[[1asa]], [[1asb]], [[1aka]] - cAAT (mutant) + pyridoxal phosphate<br />
+
**[[1asa]], [[1asb]], [[1aka]] - cAAT (mutant) + PLP<br />
**[[1gc3]], [[1b5o]], [[1b5p]], [[5bj4]] - TtAAT (mutant) + pyridoxal phosphate – ''Thermus thermophilus''<br />
**[[1gc3]], [[1b5o]], [[1b5p]], [[5bj4]] - TtAAT (mutant) + pyridoxal phosphate – ''Thermus thermophilus''<br />
**[[1gd9]] - PhAAT + pyridoxal phosphate – ''Pyrococcus horikoshii''<br />
**[[1gd9]] - PhAAT + pyridoxal phosphate – ''Pyrococcus horikoshii''<br />

Revision as of 09:49, 20 March 2019

E. coli aspartate aminotransferase complex with PLP and sulfate (PDB code 1asn)

Drag the structure with the mouse to rotate

3D structures of aspartate aminotransferase

Updated on 20-March-2019


References

  1. 1.0 1.1 Han Q, Robinson H, Cai T, Tagle DA, Li J. Biochemical and structural characterization of mouse mitochondrial aspartate aminotransferase, a newly identified kynurenine aminotransferase-IV. Biosci Rep. 2010 Oct 26. PMID:20977429 doi:10.1042/BSR20100117
  2. DeLorenzo RJ, Ruddle FH. Glutamate oxalate transaminase (GOT) genetics in Mus musculus: linkage, polymorphism, and phenotypes of the Got-2 and Got-1 loci. Biochem Genet. 1970 Apr;4(2):259-73. PMID:4193185
  3. 3.0 3.1 3.2 3.3 3.4 3.5 Jeffery CJ, Gloss LM, Petsko GA, Ringe D. The role of residues outside the active site: structural basis for function of C191 mutants of Escherichia coli aspartate aminotransferase. Protein Eng. 2000 Feb;13(2):105-12. PMID:10708649
  4. 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 Kamitori S, Okamoto A, Hirotsu K, Higuchi T, Kuramitsu S, Kagamiyama H, Matsuura Y, Katsube Y. Three-dimensional structures of aspartate aminotransferase from Escherichia coli and its mutant enzyme at 2.5 A resolution. J Biochem. 1990 Aug;108(2):175-84. PMID:2121725
  5. Palaiologos G, Hertz L, Schousboe A. Role of aspartate aminotransferase and mitochondrial dicarboxylate transport for release of endogenously and exogenously supplied neurotransmitter in glutamatergic neurons. Neurochem Res. 1989 Apr;14(4):359-66. PMID:2569674
  6. 6.0 6.1 6.2 6.3 6.4 6.5 Tran A, Longo F, Ouzan D, Bianchi D, Pradier C, Saint-Paul MC, Sattonnet C, Laffont C, Dantin S, Piche T, Benzaken S, Rampal P. Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity. Scand J Gastroenterol. 2000 Apr;35(4):433-7. PMID:10831269
  7. Cite error: Invalid <ref> tag; no text was provided for refs named AAT_Structure
  8. 8.0 8.1 8.2 8.3 8.4 Martinez-Carrion M, Tiemeier DC, Peterson DL. Conformational properties of the isoenzymes of aspartate transaminase and the enzyme-substrate complexes. Biochemistry. 1970 Jun 23;9(13):2574-82. PMID:5450225
  9. 9.0 9.1 Tretter L, Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci. 2000 Dec 15;20(24):8972-9. PMID:11124972
  10. 10.0 10.1 Tretter L, Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci. 2000 Dec 15;20(24):8972-9. PMID:11124972
  11. 11.0 11.1 Jungas RL, Halperin ML, Brosnan JT. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol Rev. 1992 Apr;72(2):419-48. PMID:1557428
  12. 12.0 12.1 Gibbs ME, Hertz L. Importance of glutamate-generating metabolic pathways for memory consolidation in chicks. J Neurosci Res. 2005 Jul 15;81(2):293-300. PMID:15929064 doi:10.1002/jnr.20548
  13. 13.0 13.1 13.2 13.3 13.4 Gonzalez-Flecha B, Cutrin JC, Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest. 1993 Feb;91(2):456-64. PMID:8432855 doi:http://dx.doi.org/10.1172/JCI116223

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Luke Spooner

Personal tools